Analyst price target range
REGENXBIO Price Target: $23.73 Average
Direct answer
REGENXBIO's average price target is $23.73.
The verified analyst range runs from $10.00 to $50.00.
The low target implies +24.5%, the high target implies +522.7%, and the range spans 498.1% of the current price.
Forecast evidence checked September 21, 2026.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.03
- Average price target
- $23.73
- High price target
- $50.00
- Low price target
- $10.00
- Low target gap
- +24.5%
- Target upside
- +195.5%
- High target gap
- +522.7%
- Target range width
- 498.1%
- Consensus rating
- none
- Analysts
- 11
- Evidence date
- September 21, 2026
- Valid through
- September 28, 2026
Explore related company data
Read the frequently asked questions.
What is REGENXBIO's average price target?
REGENXBIO's verified average price target is $23.73. The target range is $10.00 to $50.00.
How far are REGENXBIO's low and high targets from the recorded price?
The low target implies +24.5%, while the high target implies +522.7%.
How many analysts are included in REGENXBIO's consensus?
The verified consensus includes 11 analysts.
How is REGENXBIO's target upside or downside calculated?
The average target of $23.73 is divided by the recorded price of $8.03, then one is subtracted to produce +195.5%. This does not guarantee a future return.
When was REGENXBIO's analyst forecast verified?
The data was verified on 2026-09-21. The dataset is valid through 2026-09-28.